????對(duì)于持有Living Proof的股份可能導(dǎo)致的風(fēng)險(xiǎn)，安妮斯頓表示并不擔(dān)心?！拔也⒉痪o張，因?yàn)槲曳浅Ｏ嘈胚@家公司，我等待的只是成功。”安妮斯頓對(duì)公司事務(wù)參與得十分積極，甚至還幫忙做產(chǎn)品決策。最近在她的勸說下，研發(fā)團(tuán)隊(duì)換了洗發(fā)水的香味。另外，安妮斯頓還協(xié)助公司設(shè)計(jì)了Living Proof的專柜，很快就會(huì)在劍橋開張。她說：“不是簡(jiǎn)單地代言一款產(chǎn)品，這樣就會(huì)對(duì)它進(jìn)行更多的投資，希望它變得更出色。希望它有效，希望它說到做到?！?/p>

????盡管安妮斯頓喜歡Living Proof的洗發(fā)水，但我們估計(jì)看不到安妮斯頓代言這家公司的Neotensil產(chǎn)品了。安妮斯頓是護(hù)膚品牌艾維諾（Aveeno）的代言人，不允許公開推廣其它護(hù)膚產(chǎn)品。不過貝勞德表示，安妮斯頓仍然可以同時(shí)與這兩家公司合作，因?yàn)镹eotensil與艾維諾的產(chǎn)品沒有競(jìng)爭(zhēng)關(guān)系。Neotensil只通過威朗公司（Valeant）的醫(yī)師網(wǎng)絡(luò)銷售。Living Proof公司今年一月與威朗公司達(dá)成了一項(xiàng)銷售協(xié)議，雙方?jīng)Q定對(duì)利潤(rùn)六四分成，消費(fèi)者使用七周Neotensil的費(fèi)用是500美元。

????蘭格指出，Neotensil只是在Strateris基礎(chǔ)上開發(fā)的第一款產(chǎn)品?！爸劣谖磥頃?huì)發(fā)生什么，我對(duì)于這個(gè)問題不是專家，但我可以說說未來有可能發(fā)生么?！边@個(gè)平臺(tái)可能會(huì)用來治療脂肪團(tuán)，或用來改善牛皮癬、干燥癥等皮膚問題，或是可以延長(zhǎng)香水的香味。蘭格說：“大家可以把不同的藥劑放在這種像塑身衣一樣的面霜里，所以它在醫(yī)學(xué)和非醫(yī)學(xué)領(lǐng)域都有重大意義。”

????那么安妮斯頓對(duì)Living Proof公司有什么希望？“我只想讓女性朋友知道，現(xiàn)在已經(jīng)有了一些實(shí)實(shí)在在有用的東西，而且值得她們花出去的錢。另外就是希望公司繼續(xù)保持增長(zhǎng)?！保ㄘ?cái)富中文網(wǎng)）

????譯者：樸成奎

????Aniston isn't worried about the risk of having a financial stake in the company. "I'm not nervous because I believe in it so much. I'm just waiting for it to happen." So much so that she assists with product decisions: She recently talked the team out of changing the shampoo's fragrance and also helped design their soon-to-open storefront in Cambridge. "[To be more than] the face of a product, you're much more invested in it and want it to be great. You want it to work. You want it to mean what it says."

????Despite her love of Living Proof's shampoo, don't expect Aniston to peddle Neotensil. As the face of skincare brand Aveeno (JNJ), the actress isn't allowed to officially promote another skincare product. But Beraud says Aniston's able to continue working with both brands because Neotensil's not competitive with Aveeno products. Neotensil only sells through Valeant's (VRX) network of physicians -- Living Proof struck a $75 million distribution deal with the pharmaceutical company in January that splits profits 60/40 -- and costs $500 for 7 weeks of use.

????Langer says Neotensil is just the beginning for Strateris. "I'm no expert on what's going to happen next, but I can say what could happen next." The platform may be used to solve cellulite, help skin problems like psoriasis and xerosis, or house a long-lasting perfume. "There's a whole range of medical and non-medical implications where you can put different agents in this kind of Spanx-like cream," says Langer.

????As for Aniston's hopes for the company? "I just want women to know that there's something out there that actually works and is worth their money. And that [Living Proof] just keeps growing."